Dyne Therapeutics, Inc. (DYN)
NASDAQ·Healthcare·Biotechnology
$25.86
+2.56%
Mkt Cap $4.61B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (31 analysts)
$35.50
Range $24.00 – $47.00
Implied Upside
+37.3%
Consensus $35.50 vs current $25.86
NASDAQ·Healthcare·Biotechnology
$25.86
+2.56%
Mkt Cap $4.61B
Buy
7
Hold
0
Sell
0
Price Target (31 analysts)
$35.50
Range $24.00 – $47.00
+37.3%
Consensus $35.50 vs current $25.86